Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.
2.

Infection and nitric oxide.

Hibbs JB Jr.

J Infect Dis. 2002 Feb 15;185 Suppl 1:S9-17.

PMID:
11865435
3.

Nitric oxide production during adjuvant-induced and collagen-induced arthritis.

Cannon GW, Openshaw SJ, Hibbs JB Jr, Hoidal JR, Huecksteadt TP, Griffiths MM.

Arthritis Rheum. 1996 Oct;39(10):1677-84.

PMID:
8843858
4.
5.

High-output nitric oxide: weapon against infection?

Granger DL, Hibbs JB Jr.

Trends Microbiol. 1996 Feb;4(2):46-7. No abstract available.

PMID:
8820563
6.

Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis.

Drapier JC, Hibbs JB Jr.

Methods Enzymol. 1996;269:26-36. Review. No abstract available.

PMID:
8791634
7.

Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction.

Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr.

Methods Enzymol. 1996;268:142-51. No abstract available.

PMID:
8782580
8.

Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor.

Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB Jr, Samlowski WE.

J Immunol. 1995 Nov 1;155(9):4382-90.

PMID:
7594598
9.

Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice.

Samlowski WE, Yim CY, McGregor JR, Kwon OD, Gonzales S, Hibbs JB Jr.

J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):166-78.

PMID:
8770772
10.

Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Seiler KP, Vavrin Z, Eichwald E, Hibbs JB Jr, Weis JJ.

Infect Immun. 1995 Oct;63(10):3886-95.

11.

Nitric oxide production during adjuvant-induced arthritis is associated with tumor necrosis factor genotype.

Cannon GW, Remmers EF, Wilder RL, Hibbs JB Jr, Griffiths MM.

Transplant Proc. 1995 Apr;27(2):1543-4. No abstract available.

PMID:
7725404
12.

Nitric oxide synthesis in patients with advanced HIV infection.

Evans TG, Rasmussen K, Wiebke G, Hibbs JB Jr.

Clin Exp Immunol. 1994 Jul;97(1):83-6.

13.

Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2.

Yim CY, Hibbs JB Jr, McGregor JR, Galinsky RE, Samlowski WE.

J Immunol. 1994 Jun 15;152(12):5796-805.

PMID:
8207209
14.

N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection.

Bastian NR, Xu S, Shao XL, Shelby J, Granger DL, Hibbs JB Jr.

Biochim Biophys Acta. 1994 May 25;1226(2):225-31.

PMID:
7515690
15.

Nitric oxide produced during murine listeriosis is protective.

Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington MK, Hibbs JB Jr, Kurlander RL.

Infect Immun. 1994 Mar;62(3):1089-100.

16.

Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets.

Bastian NR, Yim CY, Hibbs JB Jr, Samlowski WE.

J Biol Chem. 1994 Feb 18;269(7):5127-31.

17.

Assembly and regulation of NADPH oxidase and nitric oxide synthase.

Bastian NR, Hibbs JB Jr.

Curr Opin Immunol. 1994 Feb;6(1):131-9. Review.

PMID:
7513523
18.

Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection.

Woods ML 2nd, Mayer J, Evans TG, Hibbs JB Jr.

Immunol Ser. 1994;60:179-95. Review. No abstract available.

PMID:
8251567
19.

Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers.

Yim CY, Bastian NR, Smith JC, Hibbs JB Jr, Samlowski WE.

Cancer Res. 1993 Nov 15;53(22):5507-11.

20.

Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.

Evans TG, Thai L, Granger DL, Hibbs JB Jr.

J Immunol. 1993 Jul 15;151(2):907-15.

PMID:
8335918
21.
22.

Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, et al.

J Clin Invest. 1992 Mar;89(3):867-77. Erratum in: J Clin Invest 1992 Jul;90(1):295.

23.

L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.

Adams LB, Franzblau SG, Vavrin Z, Hibbs JB Jr, Krahenbuhl JL.

J Immunol. 1991 Sep 1;147(5):1642-6.

PMID:
1880420
24.

Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity.

Hibbs JB Jr.

Res Immunol. 1991 Sep;142(7):565-9; discussion 596-8. Review. No abstract available.

PMID:
1812549
25.

Activated macrophage conditioned medium: identification of the soluble factors inducing cytotoxicity and the L-arginine dependent effector mechanism.

Amber IJ, Hibbs JB Jr, Parker CJ, Johnson BB, Taintor RR, Vavrin Z.

J Leukoc Biol. 1991 Jun;49(6):610-20.

PMID:
1902865
26.
27.

Role of nitric oxide synthesis in macrophage antimicrobial activity.

Nathan CF, Hibbs JB Jr.

Curr Opin Immunol. 1991 Feb;3(1):65-70. Review.

PMID:
1711326
28.

The role of nitrogen oxides as effector molecules of parasite killing.

James SL, Hibbs JB Jr.

Parasitol Today. 1990 Sep;6(9):303-5. Erratum in: Parasitol Today. 1991 Jan;7(1): 15.

PMID:
15463371
29.
30.

EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages.

Lancaster JR Jr, Hibbs JB Jr.

Proc Natl Acad Sci U S A. 1990 Feb;87(3):1223-7.

31.

Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Granger DL, Hibbs JB Jr, Perfect JR, Durack DT.

J Clin Invest. 1990 Jan;85(1):264-73.

32.

Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.

Green SJ, Meltzer MS, Hibbs JB Jr, Nacy CA.

J Immunol. 1990 Jan 1;144(1):278-83.

PMID:
2104889
33.

Nitric oxide: a cytotoxic activated macrophage effector molecule.

Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM.

Biochem Biophys Res Commun. 1988 Nov 30;157(1):87-94. Erratum in: Biochem Biophys Res Commun 1989 Jan 31;158(2):624.

PMID:
3196352
34.
35.

Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells.

Amber IJ, Hibbs JB Jr, Taintor RR, Vavrin Z.

J Leukoc Biol. 1988 Jul;44(1):58-65.

PMID:
3292685
37.

Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.

Granger DL, Hibbs JB Jr, Perfect JR, Durack DT.

J Clin Invest. 1988 Apr;81(4):1129-36.

38.
39.

Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Hibbs JB Jr, Taintor RR, Vavrin Z.

Science. 1987 Jan 23;235(4787):473-6.

PMID:
2432665
40.
43.

Aberrant oxygen metabolism in neoplastic cells injured by cytotoxic macrophages.

Granger DL, Lehninger AL, Hibbs JB Jr.

Adv Exp Med Biol. 1985;184:51-63. No abstract available.

PMID:
4036709
44.

Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages.

Hibbs JB Jr, Taintor RR, Vavrin Z.

Biochem Biophys Res Commun. 1984 Sep 17;123(2):716-23.

PMID:
6487309
45.

Coordinate expression of macrophage procoagulant and fibrinolytic activity in vitro and in vivo.

Chapman HA Jr, Vavrin Z, Hibbs JB Jr.

J Immunol. 1983 Jan;130(1):261-6. No abstract available.

PMID:
6847882
46.
48.

Activated macrophage mediated cytotoxicity for transformed target cells.

Hibbs JB Jr, Granger DL, Cook JL, Lewis AM Jr.

Adv Exp Med Biol. 1982;146:315-35. No abstract available.

PMID:
6808812
49.

A relationship between SV40-transformed cell susceptibility to macrophage killing and tumor induction in rodents.

Cook JL, Hibbs JB Jr, Lewis AM Jr.

Adv Exp Med Biol. 1981;134:177-87. No abstract available.

PMID:
6261539

Supplemental Content

Loading ...
Support Center